MedPath
FDA Approval

tranexamic acid

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tranexamic acid(100 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tranexamic acid

Product Details

NDC Product Code
50090-5072
Application Number
ANDA212676
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
September 11, 2020
Code: 6T84R30KC1Class: ACTIBQuantity: 100 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath